Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


23.10.2017

3 BMJ
8 Clin Infect Dis
1 J Immunol
1 J Infect
9 J Infect Dis
1 JAMA
1 Lancet
2 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
8 PLoS One
23 Vaccine
2 Wkly Epidemiol Rec


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. MATTHEWS PC, Barnes E
    Hepatitis B vaccine shortage: another symptom of chronic neglect?
    BMJ. 2017;359:j4686.
    PubMed     Text format    

  2. COOMBES R
    Europe steps up action against vaccine hesitancy as measles outbreaks continue.
    BMJ. 2017;359:j4803.
    PubMed     Text format    

  3. IACOBUCCI G
    NHS staff who refuse flu vaccine this winter will have to give reasons.
    BMJ. 2017;359:j4766.
    PubMed     Text format    


    Clin Infect Dis

  4. LUCA DL, Kwong JC, Chu A, Sander B, et al
    Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. SKOFF TH, Blain AE, Watt J, Scherzinger K, et al
    Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.
    Clin Infect Dis. 2017 Sep 28. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. ARCIUOLO RJ, Jablonski RR, Zucker JR, Rosen JB, et al
    Effectiveness of Measles Vaccination and Immune Globulin Post-Exposure Prophylaxis in an Outbreak Setting-New York City, 2013.
    Clin Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. ORTIZ JR
    The challenge of vaccine policy-making with imperfect data.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format    

  8. NEMES E, Hesseling AC, Tameris M, Mauff K, et al
    Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. KJAER SK, Nygard M, Dillner J, Brooke Marshall J, et al
    A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.
    Clin Infect Dis. 2017 Oct 1. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. POEHLING KA, Caspard H, Peters TR, Belongia EA, et al
    2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. MADHI SA, Koen A, Cutland CL, Jose L, et al
    Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.
    Clin Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Immunol

  12. LEE SJ, Benoun J, Sheridan BS, Fogassy Z, et al
    Dual Immunization with SseB/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells.
    J Immunol. 2017;199:1353-1361.
    PubMed     Text format     Abstract available


    J Infect

  13. BAKER JM, Alonso WJ
    Rotavirus vaccination takes seasonal signature of childhood diarrhea back to pre-sanitation era in Brazil.
    J Infect. 2017 Oct 12. pii: S0163-4453(17)30314.
    PubMed     Text format     Abstract available


    J Infect Dis

  14. GRUPPING K, Campora L, Douha M, Heineman TC, et al
    Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. LANGLEY JM
    Vaccine Prevention of Respiratory Syncytial Virus in Older Adults: The Work Continues.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format    

  16. SKOWRONSKI DM, Chambers C, Sabaiduc S, De Serres G, et al
    Beyond antigenic match: possible agent-host and immuno-epidemiological influences on influenza vaccine effectiveness during the 2015-16 season in Canada.
    J Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. BELONGIA E
    Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format    

  18. SCHWARZ TF, Aggarwal N, Moeckesch B, Schenkenberger I, et al
    Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine co-administered with seasonal influenza vaccine in adults aged 50 years and older.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. NICHOLSON E, Piedra PA
    Local Versus Global Enterovirus (EV) Surveillance: A Discussion For The Need for Active Surveillance To Guide EV A71 Vaccines.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format    

  20. FALLOON J, Yu J, Esser MT, Villafana T, et al
    An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. OXMAN MN, Harbecke R, Koelle DM
    Clinical Usage of the Candidate Adjuvanted HZ/su Zoster Vaccine: re-vaccination of recipients of live attenuated zoster vaccine and co-administration with a seasonal influenza vaccine.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format    

  22. SKOWRONSKI DM, Chambers C, De Serres G
    Selection bias in the assessment of frailty and its role in influenza vaccine effectiveness evaluation among elderly adults.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Text format    


    JAMA

  23. FAUCI AS
    An HIV Vaccine is Essential for Ending the HIV/AIDS Pandemic.
    JAMA. 2017 Oct 9. doi: 10.1001/jama.2017.13505.
    PubMed     Text format    


    Lancet

  24. YIN Y
    HPV vaccination in China needs to be more cost-effective.
    Lancet. 2017;390:1735-1736.
    PubMed     Text format    


    Lancet Infect Dis

  25. SCHIEFFELIN JS
    An effective and safe vaccine will not be enough to prepare us for the next Ebola outbreak.
    Lancet Infect Dis. 2017 Oct 9. pii: S1473-3099(17)30575.
    PubMed     Text format    

  26. GSELL PS, Camacho A, Kucharski AJ, Watson CH, et al
    Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.
    Lancet Infect Dis. 2017 Oct 9. pii: S1473-3099(17)30541.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  27. KERR S, Van Bennekom CM, Liang JL, Mitchell AA, et al
    Tdap Vaccination Coverage During Pregnancy - Selected Sites, United States, 2006-2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:1105-1108.
    PubMed     Text format     Abstract available


    PLoS One

  28. CLARK A, Black R, Tate J, Roose A, et al
    Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements.
    PLoS One. 2017;12:e0183392.
    PubMed     Text format     Abstract available

  29. DOWELL AC, Cobby E, Wen K, Devall AJ, et al
    Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.
    PLoS One. 2017;12:e0184841.
    PubMed     Text format     Abstract available

  30. VAN DEN BIGGELAAR AHJ, Richmond PC, Fuery A, Anderson D, et al
    Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
    PLoS One. 2017;12:e0185877.
    PubMed     Text format     Abstract available

  31. HIGGINS JL, Gonzalez-Juarrero M, Bowen RA
    Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.
    PLoS One. 2017;12:e0185823.
    PubMed     Text format     Abstract available

  32. LEE YL, Lin KY, Cheng CY, Li CW, et al
    Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
    PLoS One. 2017;12:e0186338.
    PubMed     Text format     Abstract available

  33. CHEN SI
    Economic benefits of sharing and redistributing influenza vaccines when shortages occurred.
    PLoS One. 2017;12:e0186418.
    PubMed     Text format     Abstract available

  34. TI J, Li Z, Li X, Lu Y, et al
    Identification of one B-cell epitope from NS1 protein of duck Tembusu virus with monoclonal antibodies.
    PLoS One. 2017;12:e0181177.
    PubMed     Text format     Abstract available

  35. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    PubMed     Text format     Abstract available


    Vaccine

  36. OZAWA S, Wonodi C, Babalola O, Ismail T, et al
    Using best-worst scaling to rank factors affecting vaccination demand in northern Nigeria.
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31332.
    PubMed     Text format     Abstract available

  37. ANA-SOSA-BATIZ F, Johnston APR, Hogarth PM, Wines BD, et al
    Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31315.
    PubMed     Text format     Abstract available

  38. LI J, Chen S, Ge J, Lu F, et al
    A novel therapeutic vaccine composed of a rearranged human papillomavirus type 16 E6/E7 fusion protein and Fms-like tyrosine kinase-3 ligand induces CD8+ T cell responses and antitumor effect.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31203.
    PubMed     Text format     Abstract available

  39. HALSTEAD SB
    Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31361.
    PubMed     Text format     Abstract available

  40. ORTIZ JR, Hombach J
    Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines.
    Vaccine. 2017 Oct 14. pii: S0264-410X(17)31226.
    PubMed     Text format     Abstract available

  41. FREY SE, Lottenbach K, Graham I, Anderson E, et al
    A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066).
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31323.
    PubMed     Text format     Abstract available

  42. OLATUNBOSUN OD, Esterhuizen TM, Wiysonge CS
    A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa.
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31370.
    PubMed     Text format     Abstract available

  43. FREULING CM, Eggerbauer E, Finke S, Kaiser C, et al
    Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs.
    Vaccine. 2017 Oct 14. pii: S0264-410X(17)31366.
    PubMed     Text format     Abstract available

  44. MEHTA PA, Sauter S, Zhang X, Davies SM, et al
    Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.
    Vaccine. 2017 Oct 14. pii: S0264-410X(17)31394.
    PubMed     Text format     Abstract available

  45. YUE X, Zhao X, Dai Y, Shu Q, et al
    Episode of Kasabach-Merritt phenomenon following Japanese encephalitis vaccination: Case report.
    Vaccine. 2017 Oct 16. pii: S0264-410X(17)31078.
    PubMed     Text format     Abstract available

  46. TIPPINS A, Leidner AJ, Meghani M, Griffin A, et al
    Timeliness of childhood vaccination in the Federated States of Micronesia.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31356.
    PubMed     Text format     Abstract available

  47. REYBURN R, Nand D, Nguyen C, Naidu S, et al
    Validation of administrative data to estimate vaccine impact: Audit of the Fiji hospital admissions electronic database, 2007-2011 & 2014-2015.
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31363.
    PubMed     Text format     Abstract available

  48. KLUBERG SA, McGinnis DP, Hswen Y, Majumder MS, et al
    County-level assessment of United States kindergarten vaccination rates for measles mumps rubella (MMR) for the 2014-2015 school year.
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31333.
    PubMed     Text format     Abstract available

  49. IZURIETA HS, Moro PL, Chen RT
    Hospital-based collaboration for epidemiological investigation of vaccine safety: A potential solution for low and middle-income countries?
    Vaccine. 2017 Oct 12. pii: S0264-410X(17)31365.
    PubMed     Text format    

  50. BERAUD G
    Mathematical models and vaccination strategies.
    Vaccine. 2017 Oct 12. pii: S0264-410X(17)31393.
    PubMed     Text format     Abstract available

  51. MCELHANEY JE, Andrew MK, McNeil SA
    Estimating influenza vaccine effectiveness: Evolution of methods to better understand effects of confounding in older adults.
    Vaccine. 2017;35:6269-6274.
    PubMed     Text format     Abstract available

  52. PENKERT RR, Iverson A, Rosch JW, Hurwitz JL, et al
    Prevnar-13 vaccine failure in a mouse model for vitamin A deficiency.
    Vaccine. 2017;35:6264-6268.
    PubMed     Text format     Abstract available

  53. ENKEL SL, Attwell K, Snelling TL, Christian HE, et al
    'Hesitant compliers': Qualitative analysis of concerned fully-vaccinating parents.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31360.
    PubMed     Text format     Abstract available

  54. HO HJ, Chan YY, Ibrahim MAB, Wagle AA, et al
    A formative research-guided educational intervention to improve the knowledge and attitudes of seniors towards influenza and pneumococcal vaccinations.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31369.
    PubMed     Text format     Abstract available

  55. HOWLADER DR, Koley H, Maiti S, Bhaumik U, et al
    A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31319.
    PubMed     Text format     Abstract available

  56. TAYLOR S, Khan M, Muhammad A, Akpala O, et al
    Understanding vaccine hesitancy in polio eradication in northern Nigeria.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31328.
    PubMed     Text format     Abstract available

  57. HOSANGADI D, Smith PG, Giersing BK
    Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31343.
    PubMed     Text format     Abstract available

  58. FUKUSHIMA S, Kiyohara T, Ishii K, Nakano T, et al
    Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix(R)) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen(R)) for Japanese travelers to endemic countries.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31357.
    PubMed     Text format     Abstract available


    Wkly Epidemiol Rec


  59. Recommended composition of influenza virus vaccines for use in the 2018 southern hemisphere influenza season.
    Wkly Epidemiol Rec. 2017;92:625-33.
    PubMed     Text format    


  60. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec. 2017;92:633-47.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: